0.348
price up icon1.43%   0.0049
after-market After Hours: .34 -0.008 -2.30%
loading

Transcode Therapeutics Inc Stock (RNAZ) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
18.97%
3.289
4.059 5.3275 5.1308 4.9011
Interest Income/Expense
0.00971
- - - -
Operating Income/Loss
18.97%
-3.289
-4.059 -5.3275 -5.1308 -4.9011
Nonoperating Income/Loss
32.68%
-0.0378
-0.0285 0.0276 0.7892 0.0842
Income/Loss From Continuing Operations Before Tax
18.61%
-3.3268
-4.0875 -5.30 -4.3417 -4.8169
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.61%
-3.3268
-4.0875 -5.30 -4.3417 -4.8169
Net Income/Loss
18.61%
-3.3268
-4.0875 -5.30 -4.3417 -4.8169
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
436.13%
5.1424
-1.5299 3.1572 1.3195 14.40
Diluted Average Shares
436.13%
5.1424
-1.5299 3.1572 1.3195 14.40
Basic Earnings Per Share
99.32%
-0.65
-95.15 -1.68 -3.29 -0.33
Diluted Earnings Per Share
99.32%
-0.65
-95.15 -1.68 -3.29 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):